ID:PKD1_HUMAN DESCRIPTION: RecName: Full=Polycystin-1; AltName: Full=Autosomal dominant polycystic kidney disease 1 protein; Flags: Precursor; FUNCTION: Involved in renal tubulogenesis. Involved in fluid-flow mechanosensation by the primary cilium in renal epithelium (By similarity). Acts as a regulator of cilium length, together with PKD2 (By similarity). The dynamic control of cilium length is essential in the regulation of mechanotransductive signaling. The cilium length response creates a negative feedback loop whereby fluid shear-mediated deflection of the primary cilium, which decreases intracellular cAMP, leads to cilium shortening and thus decreases flow-induced signaling (By similarity). May be an ion- channel regulator. Involved in adhesive protein-protein and protein-carbohydrate interactions. SUBUNIT: Interacts with PKD2. Interacts with PRKX; involved in differentiation and controlled morphogenesis of the kidney. Interacts with NPHP1 (via SH3 domain). SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell projection, cilium (By similarity). Note=PKD1 localization to the plasma and ciliary membranes requires PKD2, is independent of PKD2 channel activity, and involves stimulation of PKD1 autoproteolytic cleavage at the GPS domain. DOMAIN: The LDL-receptor class A domain is atypical; the potential calcium-binding site is missing. PTM: After synthesis, undergoes cleavage between Leu-3048 and Thr- 3049 in the GPS domain. Cleavage at the GPS domain occurs through a cis-autoproteolytic mechanism involving an ester-intermediate via N-O acyl rearrangement. This process takes place in the early secretory pathway, depends on initial N-glycosylation, and requires the REJ domain. There is evidence that cleavage at GPS domain is incomplete. Uncleaved and cleaved products may have different functions in vivo. DISEASE: Defects in PKD1 are the cause of polycystic kidney disease 1 (PKD1) [MIM:173900]. PKD1 is characterized by progressive formation and enlargement of cysts in both kidneys, typically leading to end-stage renal disease in adult life. Cysts also occurs in the liver and other organs. Its prevalence is estimated at about 1/1000. SIMILARITY: Belongs to the polycystin family. SIMILARITY: Contains 1 C-type lectin domain. SIMILARITY: Contains 1 GPS domain. SIMILARITY: Contains 1 LDL-receptor class A domain. SIMILARITY: Contains 2 LRR (leucine-rich) repeats. SIMILARITY: Contains 1 LRRCT domain. SIMILARITY: Contains 1 LRRNT domain. SIMILARITY: Contains 17 PKD domains. SIMILARITY: Contains 1 PLAT domain. SIMILARITY: Contains 1 REJ domain. SIMILARITY: Contains 1 WSC domain. CAUTION: Variant Cys-2379 has been originally described as a benign polymorphism (PubMed:10854095). However, it is a likely pathogenic mutation (PubMed:PubMed:22508176). WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PKD1"; WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding; Note=Polycystin-1; URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_204";
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P98161
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Biological Process: GO:0001502 cartilage condensation GO:0001568 blood vessel development GO:0001701 in utero embryonic development GO:0001822 kidney development GO:0001889 liver development GO:0001892 embryonic placenta development GO:0006611 protein export from nucleus GO:0006807 nitrogen compound metabolic process GO:0006816 calcium ion transport GO:0007050 cell cycle arrest GO:0007156 homophilic cell adhesion via plasma membrane adhesion molecules GO:0007160 cell-matrix adhesion GO:0007161 calcium-independent cell-matrix adhesion GO:0007204 positive regulation of cytosolic calcium ion concentration GO:0007259 JAK-STAT cascade GO:0007507 heart development GO:0009653 anatomical structure morphogenesis GO:0018105 peptidyl-serine phosphorylation GO:0021510 spinal cord development GO:0021915 neural tube development GO:0030010 establishment of cell polarity GO:0030155 regulation of cell adhesion GO:0031659 positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle GO:0032092 positive regulation of protein binding GO:0034405 response to fluid shear stress GO:0036303 lymph vessel morphogenesis GO:0042994 cytoplasmic sequestering of transcription factor GO:0043588 skin development GO:0045944 positive regulation of transcription from RNA polymerase II promoter GO:0048565 digestive tract development GO:0048754 branching morphogenesis of an epithelial tube GO:0048806 genitalia development GO:0050982 detection of mechanical stimulus GO:0051216 cartilage development GO:0060236 regulation of mitotic spindle organization GO:0060428 lung epithelium development GO:0060674 placenta blood vessel development GO:0061136 regulation of proteasomal protein catabolic process GO:0070588 calcium ion transmembrane transport GO:0072001 renal system development GO:0072164 mesonephric tubule development GO:0072177 mesonephric duct development GO:0072205 metanephric collecting duct development GO:0072218 metanephric ascending thin limb development GO:0072237 metanephric proximal tubule development GO:0072287 metanephric distal tubule morphogenesis GO:0098609 cell-cell adhesion
U24497 - Human autosomal dominant polycystic kidney disease protein 1 (PKD1) mRNA, complete cds. L33243 - Homo sapiens polycystic kidney disease 1 protein (PKD1) mRNA, complete cds. JD068037 - Sequence 49061 from Patent EP1572962. JD451378 - Sequence 432402 from Patent EP1572962. JD152060 - Sequence 133084 from Patent EP1572962. JD135204 - Sequence 116228 from Patent EP1572962. JD112664 - Sequence 93688 from Patent EP1572962. JD076091 - Sequence 57115 from Patent EP1572962. JD388661 - Sequence 369685 from Patent EP1572962. JD431626 - Sequence 412650 from Patent EP1572962. JD492917 - Sequence 473941 from Patent EP1572962. JD451074 - Sequence 432098 from Patent EP1572962. JD409635 - Sequence 390659 from Patent EP1572962. JD387045 - Sequence 368069 from Patent EP1572962. JD149780 - Sequence 130804 from Patent EP1572962. JD481824 - Sequence 462848 from Patent EP1572962. JD561185 - Sequence 542209 from Patent EP1572962. JD035037 - Sequence 16061 from Patent EP1572962. JD219594 - Sequence 200618 from Patent EP1572962. JD122088 - Sequence 103112 from Patent EP1572962. JD161997 - Sequence 143021 from Patent EP1572962. JD527805 - Sequence 508829 from Patent EP1572962. JD086674 - Sequence 67698 from Patent EP1572962. JD483534 - Sequence 464558 from Patent EP1572962. JD361986 - Sequence 343010 from Patent EP1572962. JD429696 - Sequence 410720 from Patent EP1572962. JD368413 - Sequence 349437 from Patent EP1572962. AK309422 - Homo sapiens cDNA, FLJ99463. AB209025 - Homo sapiens mRNA for Polycystin 1 precursor variant protein. AB209675 - Homo sapiens mRNA for polycystin 1 isoform 2 precursor variant protein. LP986459 - Sequence 97 from Patent EP3201339. MA014119 - JP 2017536338-A/97: TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT. LP986457 - Sequence 95 from Patent EP3201339. MA014117 - JP 2017536338-A/95: TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT. LP986455 - Sequence 93 from Patent EP3201339. MA014115 - JP 2017536338-A/93: TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT. LP986454 - Sequence 92 from Patent EP3201339. MA014114 - JP 2017536338-A/92: TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT. LP986452 - Sequence 90 from Patent EP3201339. MA014112 - JP 2017536338-A/90: TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT. LP986450 - Sequence 88 from Patent EP3201339. MA014110 - JP 2017536338-A/88: TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT. JD317694 - Sequence 298718 from Patent EP1572962. JD520817 - Sequence 501841 from Patent EP1572962. JD137644 - Sequence 118668 from Patent EP1572962. JD290135 - Sequence 271159 from Patent EP1572962. JD423344 - Sequence 404368 from Patent EP1572962. JD128355 - Sequence 109379 from Patent EP1572962. JD054738 - Sequence 35762 from Patent EP1572962. JD448244 - Sequence 429268 from Patent EP1572962. JD141849 - Sequence 122873 from Patent EP1572962. JD394760 - Sequence 375784 from Patent EP1572962. JD483504 - Sequence 464528 from Patent EP1572962. DQ600103 - Homo sapiens piRNA piR-38169, complete sequence. JD124684 - Sequence 105708 from Patent EP1572962. JD476391 - Sequence 457415 from Patent EP1572962. JD144195 - Sequence 125219 from Patent EP1572962. JD150029 - Sequence 131053 from Patent EP1572962. JD380353 - Sequence 361377 from Patent EP1572962. JD131263 - Sequence 112287 from Patent EP1572962. JD074668 - Sequence 55692 from Patent EP1572962. JD083851 - Sequence 64875 from Patent EP1572962. JD216773 - Sequence 197797 from Patent EP1572962. JD289087 - Sequence 270111 from Patent EP1572962. JD364016 - Sequence 345040 from Patent EP1572962. JD496431 - Sequence 477455 from Patent EP1572962. JD124998 - Sequence 106022 from Patent EP1572962. JD220747 - Sequence 201771 from Patent EP1572962. JD231211 - Sequence 212235 from Patent EP1572962. JD399588 - Sequence 380612 from Patent EP1572962. JD394732 - Sequence 375756 from Patent EP1572962. JD535946 - Sequence 516970 from Patent EP1572962. JD108599 - Sequence 89623 from Patent EP1572962. JD142272 - Sequence 123296 from Patent EP1572962. JD041963 - Sequence 22987 from Patent EP1572962. JD148743 - Sequence 129767 from Patent EP1572962. JD546498 - Sequence 527522 from Patent EP1572962. JD057103 - Sequence 38127 from Patent EP1572962. JD081332 - Sequence 62356 from Patent EP1572962. JD131925 - Sequence 112949 from Patent EP1572962. JD458624 - Sequence 439648 from Patent EP1572962. JD200570 - Sequence 181594 from Patent EP1572962. JD108978 - Sequence 90002 from Patent EP1572962. JD142690 - Sequence 123714 from Patent EP1572962. JD407148 - Sequence 388172 from Patent EP1572962. JD185626 - Sequence 166650 from Patent EP1572962. JD185188 - Sequence 166212 from Patent EP1572962. JD257328 - Sequence 238352 from Patent EP1572962. JD172744 - Sequence 153768 from Patent EP1572962. JD389746 - Sequence 370770 from Patent EP1572962. JD059954 - Sequence 40978 from Patent EP1572962. JD227440 - Sequence 208464 from Patent EP1572962. JD498004 - Sequence 479028 from Patent EP1572962. JD051791 - Sequence 32815 from Patent EP1572962. JD431945 - Sequence 412969 from Patent EP1572962. JD133140 - Sequence 114164 from Patent EP1572962. JD192880 - Sequence 173904 from Patent EP1572962. JD462095 - Sequence 443119 from Patent EP1572962. JD129333 - Sequence 110357 from Patent EP1572962. DL489985 - Novel nucleic acids.
Biochemical and Signaling Pathways
Reactome (by CSHL, EBI, and GO)
Protein P98161 (Reactome details) participates in the following event(s):
R-HSA-5620914 ARF4:GTP binds VxPx-motifs of membrane proteins R-HSA-5620918 ASAP1 dimer binds membrane proteins R-HSA-5623519 RAB3IP and RAB8A bind to the ciliary targeting complex R-HSA-5623513 ASAP1 stimulates GTPase activity of ARF4 R-HSA-5620921 ASAP1 recruits RAB11FIP3 and RAB11 to the ciliary targeting complex R-HSA-5623521 RAB3IP stimulates nucleotide exchange on RAB8A R-HSA-5623524 The exocyst complex binds to RAB3IP in the ciliary targeting complex R-HSA-5620916 VxPx cargo-targeting to cilium R-HSA-5620920 Cargo trafficking to the periciliary membrane R-HSA-5617833 Cilium Assembly R-HSA-1852241 Organelle biogenesis and maintenance